MRVIMaravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A1,026
Mkt Cap
$1.13BVolume
1.51M52W High
$5.0052W Low
$1.99PE Ratio
-6.05MRVI Fundamentals
Price
$4.66Prev Close
$4.37Open
$4.3750D MA
$3.59Beta
1.24Avg. Volume
1.87MEPS (Annual)
-$0.9059P/B
3.05Rev/Employee
$426,995.40$777.32
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference in June. On June 4, 2026, at 12:50 p.m. Eastern Time, Raj Asarpota, Chief...
Business Wire
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of +121.41% and +20.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Maravai LifeSciences Reports First Quarter 2026 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the...
Business Wire
All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy
Maravai LifeSciences (MRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are currently covering the stock, Marketbeat reports...
MarketBeat
Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates
Baxter (BAX) delivered earnings and revenue surprises of +15.42% and +3.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday
Maravai LifeSciences (NASDAQ:MRVI) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) saw some unusual options trading on Wednesday. Traders acquired 1,002 put options on the stock. This is an increase of approximately 1,791% compared to the average volume of 53 put options...
MarketBeat
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial...
Business Wire
Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of some unusual options trading on Wednesday. Investors bought 1,002 put options on the stock. This represents an...
MarketBeat
<
1
2
...
>
Compact View
Not available
Not available